Company Name
Modalis Therapeutics Corporation
Foundation
Jan 2016
Representative Directors
Haru Morita
Headquarters
3-11-5 Nihonbashi-Honcho, Nihonbashi-Lifescience-Bldg.2 7F Chuo-ku, Tokyo,103-0023 JAPAN
U.S. subdiary
Modalis Therapeutics Inc.
(43 Foundry Avenue, Waltham, Massachusetts, 02453 USA)
Japan Location
3-11-5 Nihonbashi-Honcho, Nihonbashi-Lifescience-Bldg.2 7F Chuo-ku, Tokyo,103-0023 JAPAN
US Location
43 Foundry Avenue, Waltham, Massachusetts, 02453 USA
Corporate Symbol
The name MODALIS was chosen in the hope that our new drug discovery technology (MODALITY) will lead to the creation of gene therapy drugs in the future.
The logo’s central feature is a mark derived from the epigenome’s role as a “gene switch,” which we believe is the target of CRISPR-GNDM® technology and the key to treating genetic diseases.
EN